FDA Approved: PALIPERIDONE — Supplemental Application (ANI Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved ANI Pharmaceuticals' supplemental application to bring a generic paliperidone product to market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizoaffective Disorder
• Schizophrenia

Drugs mentioned

• PALIPERIDONE (paliperidone)

Snippet

SUPPL AP for PALIPERIDONE (PALIPERIDONE)